Genetic variability in Paraoxonase 1 (PON1), an HDL associated esterase: impact on risk and pharmacokinetics

Published on October 1, 2007 Archived on December 10, 2018   51 min

Other Talks in the Therapeutic Area: Cardiovascular & Metabolic

Hide

Genetic variability in Paraoxonase 1 (PON1), an HDL associated esterase: impact on risk and pharmacokinetics

Embed in course/own notes